Authors
Loading...
Study finds complement activation in sickle cell disease patients with rapidly progressive acute chest syndrome, suggesting implications for treatment with eculizumab.
Figueroa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: